Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cell Cycle Checkpoints

Known as: Checkpoint, Checkpoints, Cell Cycle, Cell Cycle Checkpoint 
Regulatory signaling systems that control the progression through the CELL CYCLE. They ensure that the cell has completed, in the correct order and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include… Expand
  • figure 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Tertiary lymphoid structures (TLSs) are ectopic lymphoid organs that develop in non-lymphoid tissues at sites of chronic… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Review
2019
Review
2019
Tumor metastasis is a major contributor to the death of cancer patients. It is driven not only by the intrinsic alterations in… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Review
2019
Review
2019
New therapies that promote antitumour immunity have been recently developed. Most of these immunomodulatory approaches have… Expand
  • table 1
  • figure 1
  • figure 2
Review
2019
Review
2019
The emergence of immune checkpoint blockade therapies over the last decade has transformed cancer treatment in a wide range of… Expand
Review
2019
Review
2019
Immunotherapies have led to substantial changes in cancer treatment and have been a persistently popular topic in cancer research… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2019
Review
2019
Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety… Expand
  • figure 1
  • figure 2
Review
2019
Review
2019
Immune checkpoint inhibitor (ICI) activates host’s anti-tumor immune response by blocking negative regulatory immune signals. A… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Review
2019
Review
2019
In the wake of the success of modern immunotherapy, oncolytic viruses (OVs) are currently seen as a potential therapeutic option… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Review
2019
Review
2019
Immune-checkpoint inhibitors (ICIs), including anti-cytotoxic T lymphocyte antigen 4 (CTLA-4), anti-programmed cell death 1 (PD-1… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2